Background: Subarachnoid S(+)-ketamine is a matter of much debate as the results
regarding its toxicity are contradictory.
Objectives: Our objective was to investigate possible histopathological alterations after
subarachnoid administration of different doses of preservative-free S(+)-ketamine to dogs.
Study design: A randomized, blind, prospective experimental study.
Setting: Center for Research on Pain at the Federal University of Maranhão, Brazil.
Methods: Sixteen adult mongrel dogs of both sexes, each weighing 11 to 20 kg were
divided into 3 groups: Group I (n=6), 0.7 mg/kg-1 S(+)-ketamine; Group II (n=6), 0.5 mg/
kg-1 S(+)-ketamine, and a control group, Group III, (n=4), 0.9% NaCl. All substances were
administered in one mL volume doses. The animals were kept in captivity for 2 weeks; after
this period, they were put down and lumbar and sacral portions of the spinal cords were
removed for histological examination using conventional light microscopy.
Results: There were histological alterations in the spinal cords of the test subjects in
the control group. Comparison showed significant histological abnormalities in Groups
I and II when compared to the control group, including gliosis, axonal edema, central
chromatolysis, lymphocyte infiltration and fibrous thickening of the dura mater.
Limitations: Test subjects received only a single dose each. The observation period was
not very long, less than a month.
Conclusions: Subarachnoid administration of S(+)-ketamine without preservative caused
histological lesions on the spinal cord and meninges in the dogs studied. S(+)-ketamine
should not be given to clinical patients in this way until further evaluation of the significance
of this toxicity has been conducted.
Key words: S(+)-ketamine. subarachnoid, neurotoxicity, dog, histopathology